| Bioactivity | Zerlasiran sodium is an apolipoprotein A (ApoA) synthesis reducer[1]. |
| Name | Zerlasiran sodium |
| Formula | C443H556F12N144Na38O277P40S10 |
| Molar Mass | 14991.12 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022. |